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Abstract
Interstitial fibrosis, a histological process common to many kidney diseases, is the precursor state to end stage kidney
disease, a devastating and costly outcome for the patient and the health system. Fibrosis is historically associated with
chronic kidney disease (CKD) but emerging evidence is now linking many forms of acute kidney disease (AKD) with the
development of CKD. Indeed, we and others have observed at least some degree of fibrosis in up to 50% of clinically
defined cases of AKD. Epithelial cells of the proximal tubule (PTEC) are central in the development of kidney interstitial
fibrosis. We combine the novel techniques of laser capture microdissection and multiplex-tandem PCR to identify and
quantitate ‘‘real time’’ gene transcription profiles of purified PTEC isolated from human kidney biopsies that describe
signaling pathways associated with this pathological fibrotic process. Our results: (i) confirm previous in-vitro and animal
model studies; kidney injury molecule-1 is up-regulated in patients with acute tubular injury, inflammation, neutrophil
infiltration and a range of chronic disease diagnoses, (ii) provide data to inform treatment; complement component 3
expression correlates with inflammation and acute tubular injury, (iii) identify potential new biomarkers; proline 4-
hydroxylase transcription is down-regulated and vimentin is up-regulated across kidney diseases, (iv) describe previously
unrecognized feedback mechanisms within PTEC; Smad-3 is down-regulated in many kidney diseases suggesting a possible
negative feedback loop for TGF-b in the disease state, whilst tight junction protein-1 is up-regulated in many kidney
diseases, suggesting feedback interactions with vimentin expression. These data demonstrate that the combined
techniques of laser capture microdissection and multiplex-tandem PCR have the power to study molecular signaling within
single cell populations derived from clinically sourced tissue.
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Introduction
It is widely acknowledged that the epithelial cells of the
proximal tubule (PTEC) play a central role in interstitial fibrosis,
following cellular insults such as excessive protein exposure and
oxidative stress [1–5]. These insults lead to perturbation of the
complex interactions of growth factors, cytokines and chemokines
which maintain the homeostasis of these cells, leading to the over-
expression of genes involved in inflammatory responses [6–8] and
epithelial to mesenchymal transition (EMT) [9–12], both patho-
biological processes resulting in a fibrotic phenotype. However,
research implicating PTEC involvement in interstitial fibrosis
comes predominantly from animal models or in-vitro studies using
transformed cell lines or primary PTEC cultures. The relevance of
translating PTEC knowledge derived from these models to human
disease has not been established. Attempts to elucidate transcrip-
tion profiles in human kidney disease tissue have generally taken a
global approach, analyzing gene expression from whole kidney
biopsies [13,14] or tissue sections with mixed cellular populations
[15].
In this work we exploit the recent developments in microscopic
dissection using Laser Capture Microdissection (LCM) to target
the single cell PTEC population ex-vivo. The technology allows
the visualisation of proximal tubules within renal biopsies from
patients with kidney disease and the subsequent capture/isolation
of PTEC from these tubules using laser catapult energy [16]. This
technology has been recently used in human kidney research of
gene expression in the glomerulus [17–19], to study one or two
genes across different compartments of the kidney [20,21] or to
analyse PTEC collected from proteinuric disease biopsies using
gene microarray technology [22,23]. Gene microarray analysis
studies provide vast amounts of transcriptional data but have a
number of inherent difficulties including: (i) difficult and expensive
to undertake, (ii) require duplicate samples to eliminate artifactual
data, (iii) take weeks or months to analyse the large volumes of data
and (iv) require large amounts of input RNA or, when not
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available as occurs in the clinical setting, non-specific pre-
amplification of high quality RNA.
To remove bias, commonly encountered when non-specifically
pre-amplifying the picogram quantities of RNA typically obtained
from human biopsies using LCM, we utilised targeted gene
transcription analysis using primer-specific nested amplification.
This methodology, known as multiplex tandem-PCR (MT-PCR),
has been reported to amplify cDNA from as little as 10 picograms
of RNA and was designed to amplify degraded RNA recovered
from formalin-fixed paraffin embedded tissue [24]. Here we use
MT-PCR analysis of LCM-isolated PTEC from clinical human
kidney biopsies to provide transcriptional data on the four major
pathobiological pathways associated with kidney fibrosis: (i)
inflammation, (ii) collagen deposition, (iii) EMT and (iv) apoptosis.
We relate changes in the transcriptional profiles of the pathways to
the clinical phenotype of the patients. These technologies are
readily translatable to human diagnostics of the future where the
prognostic power of PTEC may direct therapies to specific targets.
Methods
Patient and Tissue sample details
Control tissues were obtained from the healthy portions of
malignant nephrectomies (n = 8) and were validated as normal at
the macroscopic and microscopic level by the consulting renal
pathologist. Diseased samples (n = 96) were collected from native
kidney biopsy material that were surplus to diagnostic require-
ments. Biopsies were frozen in OCT within 20 minutes of
collection and stored at 280uC prior to processing. When
biopsies/patients were grouped according to the clinical diagnosis
of acute or chronic disease, defined clinically prior to histopath-
ological diagnosis, we had a total of 26 acute, 16 chronic, 51 acute-
on-chronic and 3 undefined. Final disease diagnoses, of which
there were three or more patients per disease group (n= 87),
included IgA nephropathy (IgAN; n= 14), focal segmental
glomerulosclerosis (FSGS; n= 11), pauci-immune glomerulone-
phritis (PI; n = 11), membranous nephropathy (MN; n= 9),
interstitial nephritis (IN; n= 7), protein deposition disease (PDD;
Table 1. MT-PCR genes examined and the associated disease pathway.
Gene Symbol Official Name
House Keeping GAPDH glyceraldehyde-3-phosphate dehydrogenase
BTF3 basic transcription factor 3
Fibrosis TGFB1 transforming growth factor, beta 1
SERPINE1 serpin peptidase inhibitor, clade E, member 1
SMAD3 SMAD family member 3
COL3A1 collagen, type III, alpha 1
COL1A2 collagen, type I, alpha 2
P4HA2 proline 4-hydroxylase, alpha polypeptide II
SERPINH serpin peptidase inhibitor, clade H (heat shock protein 47), member 1
THBS1 thrombospondin 1
Inflammation TNF tumor necrosis factor (TNF superfamily, member 2)
IL6 interleukin 6 (interferon, beta 2)
IL8 interleukin 8
NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
CCL2 chemokine (C-C motif) ligand 2/monocyte chemotactic protein 1
C3 complement component 3
BMP7 bone morphogenetic protein 7 (osteogenic protein 1)
BMP6 morphogenetic protein 6
Kim-1 kidney injury molecule-1/hepatitis A virus cellular receptor 1
SPP1 secreted phosphoprotein 1 (osteopontin, early T-lymphocyte activation 1)
EMT VIM vimentin
ACTA2 actin, alpha 2, smooth muscle, aorta
TJP1 tight junction protein 1 (zona occludens 1)
S100A4 S100 calcium binding protein A4
TWIST1 twist homolog 1
SNAI1 snail homolog 1
Apoptosis BCL2 B-cell CLL/lymphoma 2
BAD BCL2-antagonist of cell death
BAX BCL2-associated X protein
CASP3 caspase 3, apoptosis-related cysteine peptidase
CASP8 caspase 8, apoptosis-related cysteine peptidase
FAS Fas (TNF receptor superfamily, member 6)
doi:10.1371/journal.pone.0087345.t001
PTEC Gene Transcription in the Pathological State
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n=7), minimal change disease (MCD; n=6), diabetic nephrop-
athy (DN; n= 6), lupus nephritis (LN; n= 5), membranoprolifera-
tive glomerulonephritis (MPGN; n= 4), thrombotic microangiop-
athy (TMA; n= 4) and acute tubular necrosis (ATN; n= 3). The
renal pathologist also scored the histological grading of the
interstitium of all disease biopsies using a scale modified from the
Banff system [25]. Briefly, overall cortical inflammation (OCI),
unscarred cortical inflammation (UCI) and interstitial fibrosis/
tubular atrophy (IF/TA) were each graded on a scale of 0–4 (0 =
not present, 1 = up to 5%, 2= 6–25%, 3= 26–50% and 4=
greater than 50%) and yes/no for the presence of acute tubular
injury (ATI), neutrophils and eosinophils. This grading was based
upon the analysis of twenty individual 4 mm sections from each
biopsy, which had been stained with haematoxylin and eosin or
Masson’s trichrome. Kidney function (estimated glomerular
filtration rate (eGFR)) was calculated using the MDRD method
by AUSLAB (Queensland Health) and proteinuria was described
by urine protein to creatinine ratio (uPCR).
Ethics statement
All disease biopsy samples were used following written informed
patient consent under human ethics approval from the Royal
Brisbane and Women’s Hospital (RBWH) (2002/011) and the
Queensland Institute of Medical Research (QIMR) (P293).
LCM
10 mm thick cryosections were cut under RNase-free conditions
and mounted on MembraneSlide 1.0 PEN slides (Carl Zeiss,
Munich, Germany) treated with 20 min of UV exposure prior to
use. Cryosections were stored at 280uC for a maximum of
48 hours or processed immediately for staining of endogenous
alkaline phosphatase, exclusively expressed by PTEC in kidney
cortex, by a one minute fixation in 70% ethanol followed by
staining with SigmaFast BCIP/NBT (Sigma-Aldrich, St Louis,
MO, USA) for 5 min. Cryosections were then dehydrated for
1 min each in 70%, 90% and 100% ethanol and PTEC were
collected from these sections for a maximum time of 30 min, after
which the process was repeated with additional sections until a
total of one million mm2 of tissue was collected. The PALM
Microlaser System (PALM Microlaser Technologies, Zeiss, Jena,
Germany) equipped with the PALM RoboSoftware controlled
microscope stage and micromanipulator was used for LCM.
PTEC were outlined at the basement membrane using the
software and isolated from surrounding tissue by laser ablation
prior to being catapulted into a Zeiss AdhesiveCap 500 Opaque
collection cap (Zeiss) for subsequent RNA isolation. One cap per
‘‘section collection’’ was used and caps were replaced on their tube
and stored on dry ice prior to RNA extraction using the Absolutely
RNA Nanoprep kit (Stratagene, Santa Clara, CA, USA) with on-
column DNase digestion. Confirming PTEC purity, initial
quantitative RT-PCR optimization experiments failed to amplify
non-PTEC expressed genes (aquaporin-2 and tamm-horsfall
protein) from three million mm2 LCM isolated PTEC (data not
shown).
Multiplex Tandem-PCR
This methodology uses two-step MT-PCR gene-disc technology
developed in commercial collaboration with AusDiagnostics Pty
Ltd (Sydney, Australia). In the first step the RNA from a single one
million mm2 PTEC extraction was converted to cDNA and
amplified in a multiplex single tube reaction for 25 cycles using
AusDiagnostics gene-specific primers and master mix reagents.
The product was then diluted 1/200 and dispensed into duplicate
individual tubes containing specific nested primers for each gene of
interest and amplified using real-time PCR for a further 45 cycles
with a SYBR Green master mix in a Rotor-Gene Q thermal cycler
(QIAGEN, Hilden, Germany). Genes were ‘‘called’’ by AusDiag-
nostics Software protocols that analyze products based upon melt
temperature, purity and quantity values. All ‘‘called’’ results were
manually verified during data analysis. Expression levels were
normalised to the internal house-keeping genes GAPDH and
BTF3 which were assigned an arbitrary value of 1000. Primer and
product sequences are not reported due to commercial in-
confidence agreements with AusDiagnostics Pty Ltd. We analyzed
a total of 30 genes in duplicate for every sample. Genes are listed
in Table 1.
Quantitative RT-PCR
Real-time PCR (RT-PCR) primers were designed and supplied
by AusDiagnostics Pty Ltd. Three million mm2 of PTEC were
extracted by LCM from biopsies and total RNA was isolated from
cells with the Absolutely RNA Nanoprep Kit (Stratagene)
according to the manufacturer’s instructions. Reverse transcription
was performed using random hexamers (Invitrogen, Grand Island,
NY, USA) and Superscript III Reverse Transcriptase (Invitrogen).
RT-PCR reactions were performed using RT2 SYBR Green
qPCR master mix (QIAGEN). GAPDH was used for normaliza-
tion of cDNA input, and RT-PCR reactions were performed using
a Rotor-Gene Q thermal cycler (QIAGEN) according to the
manufacturer’s instructions: initial denaturation at 95uC for
10 min, followed by 45–50 cycles at 95uC for 15 sec and at
60uC for 60 sec. Data analysis was performed using Rotorgene
software (QIAGEN) and the delta delta Ct (DDCt) method.
Immunohistochemistry
6 mm cryosections were prepared and dried overnight prior to
fixation in acetone/ethanol. Sections were blocked for 30 min in
4% milk and 15 min in 10% goat serum and incubated with
primary Ab diluted in Tris-buffered saline (TBS) for 1 hour at
room temperature. Primary Abs were mouse anti-human Kim-1
(Clone 219211; R&D Systems, Minneapolis, MN, USA), mouse
anti-human Collagen III (Clone FH-7A; Abcam, Hong Kong) and
mouse anti-human Vimentin (Clone V9; Dako, Glostrup, Den-
mark). Following three 5 min washes in TBS, sections were treated
Table 2. The mean log relative gene expression (normalised
to GAPDH) of nine genes able to differentiate disease from
healthy control biopsies.
Mean Control Mean Disease Disease-Control p-value
Kim-1 0.24 2.17 1.93 ,0.001
P4HA2 6.24 4.33 21.91 0.002
C3 0.55 2.15 1.6 0.024
THBS1 8.37 6.45 21.93 0.038
COL3A1 0.43 4.20 3.76 ,0.001
ACTA2 5.88 3.83 22.05 0.012
TJP1 2.40 3.86 1.46 0.033
VIM 0.22 4.34 4.12 ,0.001
FAS 4.17 6.32 2.16 0.005
Kim-1, P4HA2 and C3 also demonstrated significant differences within disease
groups based on histology (OCI, UCI, IF/TA, ATI and presence of neutrophils/
eosinophils), kidney function (eGFR) or proteinuria (uPCR), compared to
controls.
doi:10.1371/journal.pone.0087345.t002
PTEC Gene Transcription in the Pathological State
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Figure 1. Kim-1 log relative gene expression (normalised to GAPDH) from normal biopsies (Control) and biopsies with (A) overall
cortical inflammation (OCI, 0= absent, 1–2=5–25%, 3–4=26–.50%), (B) unscarred cortical inflammation (UCI, 0 =absent, 1 =,5%,
2=6–25%, 3=26–50%), (C) the presence of acute tubular injury, (D) the presence of neutrophils and (E) proteinuria, defined using
a urine protein to creatinine ratio (uPCR) (A=, 100 mg/mmol, B=100–299 mg/mmol, C=$300 mg/mmol). Values are means 6 SEM.
*P,0.05, **P,0.01, ***P,0.001, one-way ANOVA with Dunnett’s post-test.
doi:10.1371/journal.pone.0087345.g001
Figure 2. C3 log relative gene expression (normalised to GAPDH) from normal biopsies (Control) and biopsies with (A) overall
cortical inflammation (OCI, 0 = absent, 1–2=5–25%, 3–4=26–.50%), (B) the presence of acute tubular injury and (C) proteinuria,
defined using a urine protein to creatinine ratio (uPCR) (A=,100 mg/mmol, B=100–299 mg/mmol, C=$300 mg/mmol). Values are
means 6 SEM. *P,0.05, **P,0.01, one-way ANOVA with Dunnett’s post-test.
doi:10.1371/journal.pone.0087345.g002
PTEC Gene Transcription in the Pathological State
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with 1% H2O2 in TBS for 10 min to block endogenous peroxidase
prior to 30 min incubation in goat anti-mouse horseradish
peroxidase. Sections were then washed 3 times in TBS and
developed with DAB for 5 min prior to light counterstaining with
haematoxylin and eosin.
Statistical Analysis
Due to the skewed and wide distribution of the data, gene
expression values were log transformed, which enabled the
application of parametric statistics. As the log of zero is undefined,
one was added to all measurements in order to preserve the zeros
in the derived data set. Multiple comparisons of gene expression
values for disease biopsies (stratified on histopathology, renal
function, proteinuria and clinical diagnosis) against healthy
controls were performed using a one-way ANOVA with Dunnett’s
post-test. Statistical tests were performed using Prism 5.0 analysis
software (GraphPad Software, La Jolla, CA, USA). P values#0.05
were considered statistically significant.
Results
Multiplex Tandem-PCR – PTEC gene expression levels
correlate with histology, renal function and proteinuria
We initially compared the means of the disease group to the
control group for all 30 genes in the panel. A total of 9 genes
discriminated disease samples from controls: Kim-1, C3, P4HA2,
THBS1, COL3A1, ACTA2, TJP1, VIM and FAS (Table 2). For
example, the expression of Kim-1 was, on average, 1.93 units
higher in the disease group as compared to the control group and
P4HA2 was, on average, 1.91 units lower in the disease group as
compared to the control group.
We then stratified MT-PCR derived gene transcript data from
diseased samples based on: (i) histological criteria (OCI, UCI, IF/
TA, ATI and the presence of neutrophils or eosinophils), (ii) kidney
function (eGFR) and (iii) degree of proteinuria (uPCR levels).
Within these groupings, three genes, Kim-1, C3 and P4HA2
demonstrated significant differences compared to controls.
Levels of Kim-1 significantly correlated with increasing OCI
(Fig 1a), and Kim-1 expression was significantly elevated in all
disease groupings with UCI (Fig 1b). In line with the literature,
Kim-1 expression was significantly higher in biopsies with ATI
(Fig 1c) and infiltrating neutrophils (Fig 1d), histological markers of
acute kidney disease. Biopsies from patients with the heaviest
proteinuria, a marker for progression of uncontrolled kidney
disease, also demonstrated significantly elevated levels of Kim-1
expression (Fig 1e). C3 expression levels correlated positively with
OCI when compared to no inflammation and controls (Fig 2a).
Furthermore, a significant increase in C3 expression was
demonstrated in biopsies from patients with acute tubular injury
(Fig 2b) and those with the heaviest proteinuria (Fig 2c). In
contrast, P4HA2 expression was significantly lower in diseased
biopsies with eosinophils (Fig 3a), whilst a trend for decreasing
expression of P4HA2 with increasing levels of IF/TA (Fig 3b) and
decreasing kidney function (eGFR) (Fig 3c) was observed.
Multiplex Tandem-PCR – PTEC gene expression levels
correlate with clinical diagnosis
When we stratified gene results against clinical acute, chronic
and acute-on-chronic groups, we found increased expression
compared to controls of Kim-1, C3, COL3A1, VIM, SMAD3 and
TJP1 across all clinical groupings and decreased expression of
P4HA2 compared to controls across all clinical groupings (Fig 4).
However there were no significant differences of gene expression
patterns between groups for each individual gene.
When we compared gene results against biopsies grouped into
disease diagnoses, Kim-1, P4HA2, COL3A1, VIM, SMAD3 and
TJP1 were consistently expressed at different levels to control
biopsies across a number of primary diagnoses (Fig 5). The mean
expression of Kim-1 was higher than controls in biopsies from all
disease groups except TMA, and significantly higher than controls
in patients with IgAN, DN and PI (Fig 5a). The mean expression
of P4HA2 was lower than controls in biopsies from all disease
groups except MCD and significantly lower in patients with TMA
and PDD (Fig 5b). The mean expression of COL3A1 was higher
than controls in biopsies from all disease groups, and significantly
higher than controls in patients with IgAN, MN, IN, DN, PI,
ATN, PDD and FSGS (Fig 5c). The mean expression of VIM was
higher than controls in biopsies from all disease groups and
significantly higher than controls in all groups except MN (Fig 5d).
The mean expression of SMAD3 was lower than controls in
biopsies from all disease groups and significantly lower in biopsies
from PDD patients (Fig 5e). The mean expression of TJP1 was
higher than controls in biopsies from all disease groups except
TMA and significantly higher than controls in patients with DN,
LN and PI (Fig 5f).
Figure 3. P4HA2 log relative gene expression (normalised to GAPDH) from normal biopsies (Control) and biopsies with (A) the
presence of eosinophils, (B) interstitial fibrosis/tubular atrophy (IF/TA, 0= absent, 1 =,5%, 2=6–25%, 3=26–50%, 4=.50%) and
(C) chronic kidney disease (CKD) defined by estimated glomerular filtration rate (eGFR, 1 =$90 ml/min/1.73 m2, 2 =60–89 ml/min/
1.73 m2, 3=30–59 ml/min/1.73 m2, 4 =15–29 ml/min/1.73 m2, 5 =,15 ml/min/1.73 m2). Values are means 6 SEM. *P,0.05, one-way
ANOVA with Dunnett’s post-test.
doi:10.1371/journal.pone.0087345.g003
PTEC Gene Transcription in the Pathological State
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Confirmation of MT-PCR results at the molecular and
protein level
To confirm our MT-PCR results at the molecular level, we
undertook standard quantitative RT-PCR analysis of three
candidate genes from our MT-PCR screening panel. We analyzed
three different patient biopsies that had high expression of the
relevant gene by MT-PCR and three different patient biopsies
which had low/negative expression of the relevant gene by MT-
PCR. We consistently detected greater levels of Kim-1, COL3A1
and VIM from biopsies with high expression of the respective
genes compared to biopsies with no/low gene expression (Fig 6).
We performed immununohistochemical analysis of these three
gene products to correlate gene transcription levels to protein
expression in tissue. We confirmed strong staining for Kim-1,
COL3A1 and VIM in PTEC of biopsies that expressed high
transcript levels by MT-PCR, with low or negative staining
patterns in biopsies that had negative or very low transcript
expression levels by MT-PCR (Fig 7). Extracellular staining of
Kim-1 in the proteinacious material of the proximal tubule and of
COL3A1 in the interstitium, adjacent to the basement membrane,
was also noted.
Figure 4. The log relative gene expression (normalised to GAPDH) of COL3A1, Kim-1, P4HA2, VIM, TJP1, C3 and SMAD3 across
clinical acute, chronic and acute-on-chronic diagnoses. Values are means 6 SEM. *P,0.05, ***P,0.001, ****P,0.0001, one-way ANOVA with
Dunnett’s post-test.
doi:10.1371/journal.pone.0087345.g004
PTEC Gene Transcription in the Pathological State
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Discussion
PTEC are believed to play a central role in the progression of
many different types of kidney disease, irrespective of whether the
initiating aetiology occurs in the glomerulus or the interstitium.
Various insults including increased protein, elevated glucose,
AGE-modified proteins, oxidative stress, toxins, drugs and
cytokines from infiltrating inflammatory cells can all impact on
PTEC and perturb their normal physiology. The functional
consequences of this perturbed function including aberrant
chemokine secretion, EMT and cell death have primarily been
studied in cell culture and animal model systems. Using the novel
techniques of LCM and MT-PCR we have been able to
demonstrate for the first time that PTEC purified from diseased
human kidney demonstrate altered gene transcription profiles
representing multiple pathobiological pathways that associate with
markers of the clinical phenotypes of both acute and chronic
kidney disease.
Kim-1 is a phosphatidylserine receptor that recognises stress
and danger signals, like oxidized lipoproteins and apoptotic cells,
and directs them to lysosomes [26]. Kim-1 gene expression
appears quiescent under normal physiological conditions in the
kidney but is rapidly up-regulated and transcribed into protein
following injury. Kim-1 then localizes at very high levels on the
apical membrane of PTEC where its extracellular domain is
susceptible to metalloproteinase-mediated Kim-1 cleavage [26].
This soluble Kim-1, excreted in the urine, is a recognized acute
kidney injury biomarker. Our findings that PTEC expression of
Kim-1 is up-regulated in biopsies with acute tubular injury
compared to both control and disease biopsies with no acute
tubular injury is in line with the established literature. Not
unexpectedly, high Kim-1 levels in PTEC are also associated with
the presence of neutrophils, a cell of acute inflammation, in the
interstitium.
Our findings also describe a relationship between Kim-1
expression in PTEC and the histological severity of kidney
inflammation, renal function and amount of proteinuria. In
addition, we report significantly elevated levels of Kim-1 in
biopsies from patients diagnosed with IgA, DN and PI compared
to controls. A review of the literature reveals elevated levels of
Kim-1 in a number of kidney diseases. Kwon et al recently
Figure 5. The log relative gene expression (normalised to GAPDH) of Kim-1, P4HA2, COL3A1, VIM, SMAD3 and TJP1 across disease
diagnoses. Values are means 6 SEM. *P,0.05, **P,0.01, ***P,0.001, ****P,0.0001, one-way ANOVA with Dunnett’s post-test.
doi:10.1371/journal.pone.0087345.g005
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demonstrated that Kim-1 expression predicts renal outcomes in
IgA nephropathy [27], whilst elevated Kim-1 levels have also been
reported in DN [28] and decreasing levels associated with
regression of microalbuminuria in type 1 diabetes, suggesting that
tubular dysfunction is a critical component of the early course of
DN [29]. This corroboration of our findings with the established
literature is proof of concept of the validity of our LCM/MT-PCR
approach to identifying PTEC specific genes involved in the
pathobiology of kidney disease.
C3 is pivotal in the activation of the complement system and its
processing by C3 convertase to C3a and C3b is the central
reaction in both the classical and alternative complement
pathways. C3 is a known inflammatory mediator, with C3a
increasing vascular permeability and C3b promoting inflammato-
ry cell interactions. PTEC production of C3 gene transcripts and
protein has been reported in both in-vitro and in-vivo models
[30,31] and Zoja et al [31] reported the co-localisation of
interstitial inflammatory infiltrates with C3 expressing proximal
tubules. Welsh et al also reported focal PTEC expression of C3 was
always associated with localised interstitial infiltrate or focal
tubular atrophy [32]. This is supported in our findings where there
is a strong trend for increased C3 expression in disease biopsies
with OCI and a significant positive relationship between
expression of C3 and acute tubular injury. Our results support a
therapeutic strategy akin to antibiotics; that is, time dependent
therapeutic inhibitory targeting of C3 whilst the inflammatory
process is active in the pathogenesis, possibly with proteinuria as a
surrogate, and not during other pathological processes.
P4HA2 catalyses the post-translational formation of 4-hydroxy-
proline in -Xaa-Pro-Gly- sequences in collagens and other proteins
and is essential to the proper three-dimensional folding of newly
synthesized procollagen chains. To our knowledge, no other
groups have studied P4HA2 transcription in human PTEC and
only Rastaldi et al [33] have reported on the apparent up-
regulation of its protein in diseased biopsies. The significance of
decreased expressions levels of this gene in PTEC from biopsies
with moderate to severe CKD and IF/TA is therefore counter-
intuitive. However, prolyl hydroxylation via P4HA2 is part of the
pathway by which hypoxia inducible factor-1 (HIF-1) is degraded.
HIF-1 is known to regulate many important genes involved in
angiogenesis, glucose utilization, proliferation and survival includ-
ing erythropoietin, vascular endothelial growth factor and
hemeoxygenase-1 [34]. It could be hypothesized that a decrease
in PTEC expression of P4HA2 would promote the expression and
activity of HIF-1, resulting in the expression of many genes
required for survival within the compromised kidney environment
of CKD. Therefore, our findings that decreased levels of P4HA2
correlate with reduced kidney function provide a new finding that
warrants further investigation.
COL3A1 participates in the fibrotic process in the renal tubulo-
interstitium, where the abnormal extracellular matrix (ECM) in
fibrosis consists of an excess of normal components, such as
collagen type IV, and an accumulation of proteins that are absent
in the normal ECM, such as collagen type I and type III [35].
Although most collagen type III is reported to be produced by
myofibroblasts in the kidney, it has also been demonstrated to be
produced by PTEC cell lines in vitro [36] and by PTEC in diseased
kidney biopsies [33]. The finding here that PTEC also produce
COL3A1 in vivo, across a range of disease aetiologies, adds novel
findings to the PTEC literature.
VIM is the characteristic cytoskeletal protein of mesenchymal
cells and its expression in epithelial cells is a de-differentiation
marker representing an early step in EMT. In their immunohis-
tochemical studies on EMT in human biopsies, Rastaldi et al were
unable to detect any vimentin positive tubules in healthy biopsies
but reported vimentin positive PTEC from most disease biopsies
Figure 6. The log relative gene expression (normalised to GAPDH) of Kim-1, COL3A1 and VIM defined by real-time PCR from 3
biopsies with low/no MT-PCR expression (2) and 3 biopsies with medium/high MT-PCR expression (+) for that gene. Values are means
6 SEM.
doi:10.1371/journal.pone.0087345.g006
PTEC Gene Transcription in the Pathological State
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studied [33]. We hypothesize that the increased PTEC expression of
VIM transcripts in our disease biopsies reflects an early pathological
response because we rarely detected increased ACTA2, a second,
and later, marker of EMT, within PTEC. Galichon and Hertig
came to a similar conclusion, reporting that vimentin is an early and
reversible marker of EMT in kidney disease [37]. Thus, transcrip-
tion of vimentin may have potential as a kidney disease biomarker at
early and potentially reversible stages. Our observations that
ACTA2 itself did not correlate with fibrosis scores or other markers
of pathology was somewhat surprising to us as the product of this
gene has been implicated in the fibrotic process, particularly in
animal models [38]. However, others such as Rastaldi et al [33] have
also reported minimal increases of smooth muscle actin in PTEC
from human fibrotic biopsies.
SMAD3 is a member of the receptor-activated Smads (R-
Smads) which are central mediators of TGF-b signaling. Induction
and activation of the profibrotic cytokine TGF-b in the kidney,
either alone or in combination with other cytokines such as
epidermal growth factor, fibroblast growth factor-2 or angiotensin
II, induces kidney damage through a range of pathobiological
processes, including EMT, apoptosis and fibrosis (reviewed [39]).
SMAD3 is also involved in other non-redundant signaling
pathways and biological functions (reviewed [40]). We were quite
surprised to note that all of our disease biopsies had lower SMAD3
levels than our control biopsies. However the literature reports
that TGF-b can down-modulate SMAD3 gene expression in
human glomerular mesangial cells over the short term (24 hours)
and in renal tubular epithelial cells over the longer term (5–7 days)
[41]. Therefore, our group hypothesize, for the first time, that the
transcriptional inhibition of SMAD3 may form part of a biological
control loop for TGF-b within human PTEC.
TJP1 or ZO-1 is a scaffolding protein that interacts with
multiple other proteins to form and maintain tight junctions
between cells. Levels of TJP1 are relatively low in proximal tubules
compared to distal tubules (reviewed by [42]) reflecting their
greater paracellular transport functions. As proximal tubule cells
become fully differentiated they express more TJP1 [43]. This
raises the intriguing possibility that our observed increases in TJP1
transcription in most disease states is a counter-regulatory response
to the vimentin up-regulation induced early stages of PTEC
EMT– counter acting forces in the de-differentiation:differentia-
tion of PTEC homeostasis.
Collectively our study demonstrates that the technologies of
LCM coupled with MT-PCR are feasible in the clinical setting
where levels of PTEC RNA are available only in picogram
amounts. Despite the incredible complexity of PTEC transcrip-
tional profiles, their products and interactions, these technologies
provide simultaneous experimental observations of multiple
molecules of interest, informing better targeting of therapies and
potential new renal biomarkers. However, our findings do not, at
this stage, define a PTEC consensus chronic kidney disease
transcript signature, aligning with the concept that chronic disease
represents the cumulative dynamics of transient, repetitive or
persistent acute insults varying over time.
Although we have used MT-PCR to examine genes involved in
kidney pathobiology, the technique can be modified to examine any
genes or gene pathways of interest. For instance, we have recently
reported that human PTEC are able to modulate autologous
immune responses [44,45] and we are currently modifying our
protocols to examine the expression of immune mediator genes in
PTEC derived from inflammatory disease biopsies.
In conclusion, using novel methods that give unprecedented
access to real time human kidney tissue, we report alterations in
PTEC gene and protein expression, representing multiple patho-
biological pathways that associate with markers of the clinical
phenotypes of both acute and chronic kidney disease. Where the
amount of starting RNA is small, MT-PCR has the power to
simultaneously observe multiple molecules representing several
signaling pathways at the level of a single cell population. We found
the diversity of pathways implicated in kidney disease include
inflammatory, complement, collagen folding, fibrosis, cytoskeletal
and cell scaffolding pathways, ascribing PTEC a pivotal role in
regulatory networks of kidney homeostasis in health and disease.
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Figure 7. Immunohistological localization of Kim-1, COL3A1
and VIM in frozen kidney sections undertaken on (A) biopsy
negative for that gene by MT-PCR and (B) biopsy positive for
that gene by MT-PCR. Arrows indicate positive staining within PTEC.
A representative result from three donor experiments are shown (mag
6100). There is evidence of Kim-1 staining from the protainaceous
material within the lumen of some proximal tubules and COL3A1
staining is evident both within PTEC and in the interstitium, adjacent to
the basement membrane.
doi:10.1371/journal.pone.0087345.g007
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